Title:
COMPOUNDS AND COMPOSITIONS FOR TARGETED THERAPY OF RENAL DISEASES
Document Type and Number:
WIPO Patent Application WO/2023/001223
Kind Code:
A1
Abstract:
Provided herein are therapeutic compounds, for example compounds of Formula I, or pharmaceutically acceptable salts, hydrates, or solvates thereof that are therapeutic or anticancer agents, pharmaceutical compositions thereof, methods for their use, and methods for preparing these compounds.
Inventors:
GORDEEV MIKHAIL FEDOROVICH (US)
LIU JINQIAN (US)
WANG XINGHAI (CN)
LIU JINQIAN (US)
WANG XINGHAI (CN)
Application Number:
PCT/CN2022/106975
Publication Date:
January 26, 2023
Filing Date:
July 21, 2022
Export Citation:
Assignee:
SHANGHAI MICURX PHARMACEUTICAL CO LTD (CN)
International Classes:
C07K7/62; A61K47/64; A61P5/44
Domestic Patent References:
| WO2021150792A1 | 2021-07-29 | |||
| WO2016100578A2 | 2016-06-23 | |||
| WO2014014890A1 | 2014-01-23 | |||
| WO2018073449A1 | 2018-04-26 | |||
| WO2014180533A2 | 2014-11-13 |
Foreign References:
| US20180099022A1 | 2018-04-12 |
Other References:
HAMILL，K.M. ET AL.: "Polymyxins facilitate entry into mammalian cells.", CHEM. SCI., vol. 7, 25 April 2016 (2016-04-25), pages 5059 - 5068, XP055799018, DOI: 10.1039/C6SC00488A
MOONEN LIES, GERYL HILDE, D’HAESE PATRICK C., VERVAET BENJAMIN A.: "Short-term dexamethasone treatment transiently, but not permanently, attenuates fibrosis after acute-to-chronic kidney injury", BMC NEPHROLOGY, vol. 19, no. 1, 1 December 2018 (2018-12-01), XP093026399, DOI: 10.1186/s12882-018-1151-7
MOONEN LIES, GERYL HILDE, D’HAESE PATRICK C., VERVAET BENJAMIN A.: "Short-term dexamethasone treatment transiently, but not permanently, attenuates fibrosis after acute-to-chronic kidney injury", BMC NEPHROLOGY, vol. 19, no. 1, 1 December 2018 (2018-12-01), XP093026399, DOI: 10.1186/s12882-018-1151-7
Attorney, Agent or Firm:
HANQIAO PATENT (CN)
Download PDF: